Philips flags new problems with previously replaced ventilators

Published: Updated:
Read Mode
100% Font Size
1 min read

Philips, which has been struggling with a major recall of ventilators, on Monday flagged further problems with some machines it has previously replaced, according to an FDA statement.

A Philips spokesperson said that only Trilogy 100/200 ventilator models were potentially affected.

For the latest headlines, follow our Google News channel online or via the app.

The FDA said the company had notified it that the sound abatement foam could come loose in some refurbished models, “lowering the inspiratory pressure”.

In addition, trace amounts of particulate matter were found in air pathways of some reworked ventilators.

Philips has replaced more than 4 million ventilators and sleep apnea machines over the past 18 months due to worries that foam used in the machines could become toxic.

The spokesperson said Trilogy 100/200 ventilators represent around 3 percent of the recall, and no sleep apnea machines were affected.

Philips shares declined 1.3 percent to 13.55 euros in Amsterdam.

Read more:

Philips recalls ventilators due to health risks from part that may cause cancer

Philips names new Roy Jakobs CEO who has led respiratory device recall

Top Content Trending